Neuspera Medical’s percutaneous sacral neuromodulation (pSNM) has hit the “gold standard”, with 84.2% of patients suffering ...
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
The U.S. Centers for Disease Control says VRBPAC “makes the final decision about which vaccine viruses to include in the ...
The recall is classified as the second-highest risk level to consumers — meaning use of or exposure to products with the potential contamination poses a remote threat of serious adverse health ...
55m
Hosted on MSNFDA grants fast track status to Pyxis’ PYX-201The US Food and Drug Administration (FDA) has granted fast track designation to Pyxis Oncology’s antibody-drug conjugate (ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results